Nuo Therapeutics, Inc.
AURX
$1.50
$0.1259.09%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 283.70K | 683.80K | 473.00K | 366.20K | 928.70K |
Total Receivables | 248.20K | 329.20K | 305.00K | 229.80K | 250.70K |
Inventory | 150.40K | 167.80K | 216.80K | 211.40K | 209.60K |
Prepaid Expenses | 159.20K | 161.90K | 179.70K | 173.70K | 174.50K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 841.50K | 1.34M | 1.17M | 981.10K | 1.56M |
|
|||||
Total Current Assets | 841.50K | 1.34M | 1.17M | 981.10K | 1.56M |
Net Property, Plant & Equipment | 348.00K | 376.30K | 245.90K | 261.70K | 314.40K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 1.19M | 1.72M | 1.42M | 1.24M | 1.88M |
|
|||||
Total Accounts Payable | 219.20K | 385.40K | 397.60K | 486.30K | 394.50K |
Total Accrued Expenses | 292.40K | 264.00K | 230.30K | 214.70K | 188.60K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 66.90K | 64.60K | 62.40K | 60.30K | 91.40K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 578.50K | 714.00K | 690.40K | 761.30K | 674.50K |
|
|||||
Total Current Liabilities | 578.50K | 714.00K | 690.40K | 761.30K | 674.50K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 97.30K | 114.70K | 131.60K | 148.10K | 164.20K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 675.80K | 828.70K | 822.00K | 909.40K | 838.70K |
|
|||||
Common Stock & APIC | 32.77M | 32.65M | 31.78M | 30.98M | 30.98M |
Retained Earnings | -32.26M | -31.76M | -31.19M | -30.65M | -29.94M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 513.70K | 890.40K | 598.50K | 333.40K | 1.04M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 513.70K | 890.40K | 598.50K | 333.40K | 1.04M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 513.70K | 890.40K | 598.50K | 333.40K | 1.04M |
|